in

Is Singapore medtech firm Biofourmis’ near-unicorn status warranted?




We dig deeper into the inner workings of Biofourmis whose valuation quadrupled to a reported US$800 million from 2019.



Source link

What do you think?

Written by wEcZAfTxH1

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Comments

0 comments

Israeli Startup REE Unveils 3 New Prototypes For Electric Vehicle Market

Decoding the rising retail opportunities and pitfalls for ecommerce businesses